At a Glance
| Phosphatidylserine | Pregnenolone | |
|---|---|---|
| Class | Nootropic, Neuroprotective | Neurosteroid, Nootropic, Neuroprotective |
| Common Dose (oral) | 200–400 mg | 15–50 mg |
| Total Duration | — | 1–2 hrs |
| Routes | Oral | Oral |
Phosphatidylserine, a Nootropic, Neuroprotective, and Pregnenolone, a Neurosteroid, Nootropic, Neuroprotective, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. Phosphatidylserine is classified as a Nootropic, Neuroprotective while Pregnenolone is a Neurosteroid, Nootropic, Neuroprotective, meaning they approach altered states through different pharmacological mechanisms. They share 2 documented effects in common, with 5 effects unique to Phosphatidylserine and 4 unique to Pregnenolone. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| Phosphatidylserine | Pregnenolone | |
|---|---|---|
| Class | Nootropic, Neuroprotective | Neurosteroid, Nootropic, Neuroprotective |
| Common Dose (oral) | 200–400 mg | 15–50 mg |
| Total Duration | — | 1–2 hrs |
| Routes | Oral | Oral |
| Effects | 7 documented | 6 documented |
| Level | Phosphatidylserine | Pregnenolone |
|---|---|---|
| Light | 100–200 mg | 5–15 mg |
| Common | 200–400 mg | 15–50 mg |
| Strong | 400–600 mg | 50–100 mg |
| Heavy | — mg | 500 mg |
Phosphatidylserine
Pregnenolone
No direct interaction data available between these substances. This does not mean the combination is safe.
No dangerous interactions recorded.
No dangerous interactions recorded.